T46

Non-Billable

Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system

T46 should not be used for reimbursement purposes as there are multiple sub-diagnoses that fall under this code. Please refer to the sub-diagnoses below.

Related Diagnoses

  • T46.0Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action
    • T46.0XPoisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action
      • T46.0X1Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional)
      • T46.0X2Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm
      • T46.0X3Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault
      • T46.0X4Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined
      • T46.0X5Adverse effect of cardiac-stimulant glycosides and drugs of similar action
      • T46.0X6Underdosing of cardiac-stimulant glycosides and drugs of similar action
  • T46.1Poisoning by, adverse effect of and underdosing of calcium-channel blockers
    • T46.1XPoisoning by, adverse effect of and underdosing of calcium-channel blockers
      • T46.1X1Poisoning by calcium-channel blockers, accidental (unintentional)
      • T46.1X2Poisoning by calcium-channel blockers, intentional self-harm
      • T46.1X3Poisoning by calcium-channel blockers, assault
      • T46.1X4Poisoning by calcium-channel blockers, undetermined
      • T46.1X5Adverse effect of calcium-channel blockers
      • T46.1X6Underdosing of calcium-channel blockers
  • T46.2Poisoning by, adverse effect of and underdosing of other antidysrhythmic drugs, not elsewhere classified
    • T46.2XPoisoning by, adverse effect of and underdosing of other antidysrhythmic drugs
      • T46.2X1Poisoning by other antidysrhythmic drugs, accidental (unintentional)
      • T46.2X2Poisoning by other antidysrhythmic drugs, intentional self-harm
      • T46.2X3Poisoning by other antidysrhythmic drugs, assault
      • T46.2X4Poisoning by other antidysrhythmic drugs, undetermined
      • T46.2X5Adverse effect of other antidysrhythmic drugs
      • T46.2X6Underdosing of other antidysrhythmic drugs
  • T46.3Poisoning by, adverse effect of and underdosing of coronary vasodilators
    • T46.3XPoisoning by, adverse effect of and underdosing of coronary vasodilators
      • T46.3X1Poisoning by coronary vasodilators, accidental (unintentional)
      • T46.3X2Poisoning by coronary vasodilators, intentional self-harm
      • T46.3X3Poisoning by coronary vasodilators, assault
      • T46.3X4Poisoning by coronary vasodilators, undetermined
      • T46.3X5Adverse effect of coronary vasodilators
      • T46.3X6Underdosing of coronary vasodilators
  • T46.4Poisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors
    • T46.4XPoisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors
      • T46.4X1Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional)
      • T46.4X2Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm
      • T46.4X3Poisoning by angiotensin-converting-enzyme inhibitors, assault
      • T46.4X4Poisoning by angiotensin-converting-enzyme inhibitors, undetermined
      • T46.4X5Adverse effect of angiotensin-converting-enzyme inhibitors
      • T46.4X6Underdosing of angiotensin-converting-enzyme inhibitors
  • T46.5Poisoning by, adverse effect of and underdosing of other antihypertensive drugs
    • T46.5XPoisoning by, adverse effect of and underdosing of other antihypertensive drugs
      • T46.5X1Poisoning by other antihypertensive drugs, accidental (unintentional)
      • T46.5X2Poisoning by other antihypertensive drugs, intentional self-harm
      • T46.5X3Poisoning by other antihypertensive drugs, assault
      • T46.5X4Poisoning by other antihypertensive drugs, undetermined
      • T46.5X5Adverse effect of other antihypertensive drugs
      • T46.5X6Underdosing of other antihypertensive drugs
  • T46.6Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs
    • T46.6XPoisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs
      • T46.6X1Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional)
      • T46.6X2Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm
      • T46.6X3Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault
      • T46.6X4Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined
      • T46.6X5Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs
      • T46.6X6Underdosing of antihyperlipidemic and antiarteriosclerotic drugs
  • T46.7Poisoning by, adverse effect of and underdosing of peripheral vasodilators
    • T46.7XPoisoning by, adverse effect of and underdosing of peripheral vasodilators
      • T46.7X1Poisoning by peripheral vasodilators, accidental (unintentional)
      • T46.7X2Poisoning by peripheral vasodilators, intentional self-harm
      • T46.7X3Poisoning by peripheral vasodilators, assault
      • T46.7X4Poisoning by peripheral vasodilators, undetermined
      • T46.7X5Adverse effect of peripheral vasodilators
      • T46.7X6Underdosing of peripheral vasodilators
  • T46.8Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents
    • T46.8XPoisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents
      • T46.8X1Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional)
      • T46.8X2Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm
      • T46.8X3Poisoning by antivaricose drugs, including sclerosing agents, assault
      • T46.8X4Poisoning by antivaricose drugs, including sclerosing agents, undetermined
      • T46.8X5Adverse effect of antivaricose drugs, including sclerosing agents
      • T46.8X6Underdosing of antivaricose drugs, including sclerosing agents
  • T46.9Poisoning by, adverse effect of and underdosing of other and unspecified agents primarily affecting the cardiovascular system
    • T46.90Poisoning by, adverse effect of and underdosing of unspecified agents primarily affecting the cardiovascular system
      • T46.901Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional)
      • T46.902Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm
      • T46.903Poisoning by unspecified agents primarily affecting the cardiovascular system, assault
      • T46.904Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined
      • T46.905Adverse effect of unspecified agents primarily affecting the cardiovascular system
      • T46.906Underdosing of unspecified agents primarily affecting the cardiovascular system
    • T46.99Poisoning by, adverse effect of and underdosing of other agents primarily affecting the cardiovascular system
      • T46.991Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional)
      • T46.992Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm
      • T46.993Poisoning by other agents primarily affecting the cardiovascular system, assault
      • T46.994Poisoning by other agents primarily affecting the cardiovascular system, undetermined
      • T46.995Adverse effect of other agents primarily affecting the cardiovascular system
      • T46.996Underdosing of other agents primarily affecting the cardiovascular system
AI Search
Analyze diagnoses and doctors notes